Hims vs Ro for Weight Loss (2026): Prices, Medications, and How to Choose
Quick Answer: Hims or Ro for weight loss — what's the real difference?
Less than you'd think. As of August 2026 both sell only brand-name GLP-1s (Wegovy, Zepbound, Ozempic and newer options), both charge a $39 first-month membership that renews at $149/month, and both bill medication separately on top. The decision usually comes down to medication availability, insurance support, and which app experience you prefer — not price.
Hims and Ro are the two most-advertised names in telehealth weight loss, and both are legitimate: licensed providers, real pharmacies, LegitScript certification. If you're choosing between them, the honest news is that in 2026 their weight loss programs have converged to look remarkably similar. Here's the side-by-side.
What Changed in 2026
The biggest shift: neither platform sells compounded semaglutide anymore. Hims wound down its compounded semaglutide program for new patients after settling with Novo Nordisk (the maker of Wegovy and Ozempic) in early 2026, and Ro's program now lists only brand-name, FDA-approved medications. Both are now effectively storefronts plus medical care for branded GLP-1s — which makes their pricing easier to compare directly with manufacturer programs like NovoCare and LillyDirect.
Side-by-Side Pricing (August 2026)
| Factor | Hims | Ro |
|---|---|---|
| Membership fee | $39 first month, renews at $149/mo; billed separately from medication | $39 first month, then $149/mo — or about $74/mo prepaid annually |
| Wegovy (oral) | From $149/mo + membership | Offered; price shown at checkout |
| Wegovy (pen) | From $199/mo + membership | $199/mo first two months (starter doses), then $399/mo + membership |
| Zepbound | From $299/mo (vial or KwikPen) + membership | $299/mo (2.5 mg) to $449/mo (7.5–15 mg) + membership |
| Compounded GLP-1s | No longer available to new patients | Not offered |
| Insurance help | Cash-pay focus; FSA/HSA accepted | Insurance support and prior-authorization assistance included |
Prices from hims.com and ro.co public pricing pages, August 2026. Both companies change prices and promotions frequently — always confirm current pricing on their sites.
Add it up and a typical month on either platform runs roughly $300–$600 once the membership fee is included, depending on medication and dose. Notice the pattern both share: the advertised "from" price is a starter dose or limited-time offer, and the price steps up as your dose is titrated to maintenance levels.
How to Actually Choose
- Using insurance? Ro's built-in prior-authorization support is a real advantage if your plan may cover a GLP-1.
- Paying cash for a brand-name drug? Compare both platforms against manufacturer-direct programs (NovoCare for Wegovy, LillyDirect for Zepbound), which sell many of the same doses at similar or lower prices with no membership fee.
- Cost is the deciding factor? Compounded GLP-1 programs on smaller platforms typically run $99–$235/month all-in. FitFlowRx (that's us) publishes flat pricing — compounded semaglutide from $99/mo and compounded tirzepatide from $134/mo — with the consultation, medication if prescribed, and shipping included, and the price doesn't increase as your dose is titrated up. Compounded medications are prepared by licensed US compounding pharmacies pursuant to a provider's prescription; they are not FDA-approved.
The Part That Doesn't Vary by Platform
GLP-1 medications are prescription drugs with real side effects — most commonly nausea, vomiting, diarrhea, and constipation — and they aren't appropriate for everyone. People with a personal or family history of medullary thyroid carcinoma or MEN 2, a history of pancreatitis, or who are pregnant or planning pregnancy should not take them. Whichever platform you choose, the intake exists so a licensed provider can decide whether treatment is appropriate for you — and no reputable platform guarantees a prescription or a result. See our guide to GLP-1 eligibility for what screening looks like.
Frequently Asked Questions
Which is cheaper for weight loss, Hims or Ro?
Their structures are nearly identical as of August 2026: both charge a membership of $39 for the first month that renews at $149/month, with medication billed separately. Medication prices overlap heavily — for example, Zepbound from $299/month at both. Total monthly cost depends mostly on which medication and dose you're prescribed, not which platform you pick. Prices change; verify on each site.
Do Hims or Ro still sell compounded semaglutide?
No. As of 2026 both platforms sell only brand-name, FDA-approved GLP-1 medications such as Wegovy, Zepbound, and Ozempic. Hims wound down compounded semaglutide for new patients following its 2026 settlement with Novo Nordisk, and Ro's program is brand-name only. Some smaller telehealth platforms, including FitFlowRx and Found, still offer compounded GLP-1 programs through licensed US compounding pharmacies. Compounded medications are not FDA-approved.
Is the Hims or Ro membership fee refundable if I'm not prescribed medication?
The membership at both platforms is billed separately from medication and does not guarantee a prescription — a licensed provider decides whether treatment is appropriate. Review each platform's current refund and cancellation terms before signing up, as they change and vary by state.
Are there alternatives to Hims and Ro with no membership fee?
Yes. Manufacturer-direct pharmacies (NovoCare for Wegovy, LillyDirect for Zepbound) sell to self-pay patients without a platform membership, though you need a prescription. Telehealth platforms like FitFlowRx publish all-in prices — consultation, medication if prescribed, and shipping included — with no separate membership fee; FitFlowRx's compounded semaglutide programs start at $99/month. Compounded medications are not FDA-approved.
This article is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any weight loss medication. FitFlow is a telehealth platform and does not manufacture or compound medications. Compounded medications are prepared and dispensed by licensed U.S. compounding pharmacies pursuant to a prescription from a licensed provider; compounded drugs are not FDA-approved. Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. FitFlowRx is not affiliated with Hims, Ro, Novo Nordisk, or Eli Lilly.
Prefer flat, all-in pricing?
Semaglutide from $99/mo. Tirzepatide from $134/mo. No membership fee, and the price stays the same at every dose.